Abstract PD06-07: Sentinel Node Biopsy Alone for Node Positive Breast Cancer, Report from the American College of Surgeon's National Cancer Database, 1998-2007
| العنوان: | Abstract PD06-07: Sentinel Node Biopsy Alone for Node Positive Breast Cancer, Report from the American College of Surgeon's National Cancer Database, 1998-2007 |
|---|---|
| المؤلفون: | David J. Winchester, Dp. Winchester, G Addie, Katharine Yao, Hongyan Du, N Jaskowiak, S Trocha, Ermilo Barrera |
| المصدر: | Cancer Research. 70:PD06-07 |
| بيانات النشر: | American Association for Cancer Research (AACR), 2010. |
| سنة النشر: | 2010 |
| مصطلحات موضوعية: | Cancer Research, medicine.medical_specialty, medicine.diagnostic_test, business.industry, Node (networking), Cancer, Sentinel node, medicine.disease, Surgery, Breast cancer, Oncology, Biopsy, Medicine, Radiology, business |
| الوصف: | Background: The decision to perform complete node dissection for a tumor positive sentinel node (SN) has become controversial especially in light of the results of a randomized trial of sentinel node biopsy alone for node positive disease. We report national trends in the United States of SN biopsy alone from 1998-2007 for node positive disease from the National Cancer Database (NCDB) of the American College of Surgeons. Patients and Methods: Utilizing the NCDB Participant User File we analyzed 994,883 patients diagnosed with invasive breast cancer from 1998 to 2007. Neoadjuvant cases and patients with clinically positive axillary nodes were excluded. All patients underwent breast surgery. After applying exclusion criteria, 104,548 SN tumor positive patients were identified. 15,643 (14.9%) patients underwent SN biopsy alone and 88,905 (85.1%) patients underwent SN biopsy followed by completion axillary node dissection. Cross tabulations with patient, tumor and hospital factors were performed. Results: Over the 10 year period, there was a statistically significant increase in the number of patients undergoing SN biopsy alone, with 488 (9%) in 1998, and 1798 (17%) in 2007 (P Conclusions: The utilization of SN biopsy alone for patients with node positive breast cancer has significantly increased from 1998 to 2007. Patient age, tumor size, and socioeconomic status, were significant predictive variables but facility type was not. Citation Information: Cancer Res 2010;70(24 Suppl):Abstract nr PD06-07. |
| تدمد: | 1538-7445 0008-5472 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_________::cbf728ada2c874c2e1601c97c2d690f9 https://doi.org/10.1158/0008-5472.sabcs10-pd06-07 |
| رقم الأكسشن: | edsair.doi...........cbf728ada2c874c2e1601c97c2d690f9 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 15387445 00085472 |
|---|